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A 52-year-old woman with systemic lupus erythematosus presented with a 1-monthhistory of exertional dyspnea and lower-extremity edema. She had been taking hy-droxychloroquine as a disease-modifying agent for about 15 years.
A transthoracic echocardiogram showed reduced left ventricular function with an ejection
fraction of 35% (A, Online Video 1). Subsequent coronary angiography revealed normal coro-
nary arteries. Endomyocardial biopsy specimens were obtained. Hematoxylin and eosin staining
revealed myocyte vacuolization (B). Periodic-acid Schiff staining showed glycogen deposition in
myocyte cytoplasm. Transmission electron microscopy (C) demonstrated lamellar lysosomal
structures (black arrows). On the basis of these classic findings, a diagnosis of hydroxychloro-
quine cardiomyopathy was made, and the drug was discontinued.
Three months later her symptoms had completely resolved. Repeat imaging using cardiac
magnetic resonance demonstrated an ejection fraction of 65% (D, Online Video 2).
The differential diagnosis for left ventricular dysfunction in systemic lupus erythematosus
patients is wide and includes coronary artery disease, myocarditis, and valvular disease. This
case illustrates the importance of also considering hydroxychloroquine toxicity, as it can be re-
versed by cessation of the drug.
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